Takara Bio USA Holdings and Rubicon Genomics Announce Merger Agreement
Monday, December 19, 2016
Posted by: Kate Oesterle
MOUNTAIN VIEW, Calif. and ANN ARBOR, Mich./PRNewswire/ -- Takara Bio USA Holdings, Inc. ("TBUSH") and Rubicon Genomics, Inc. ("Rubicon"), today announced the signing of a merger agreement pursuant to which TBUSH will acquire Rubicon, a privately-owned company headquartered in Ann Arbor, Michigan. Rubicon is a leading provider of pre-analytical library preparation kits that increase the accuracy, efficiency and speed of genomic analysis. TBUSH is a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), a leading global biotechnology and life science company headquartered in Shiga, Japan. Takara Bio USA, Inc. ("TBUSA", formerly known as Clontech Laboratories, Inc.) is a wholly owned subsidiary of TBUSH, and both TBUSA and TBUSH are part of the global Takara Bio Group.
The Takara Bio Group provides a wide range of life science products and services under the Takara®, Clontech®, and Cellartis® brands that assist discovery, translational and clinical scientists in the advancement of their work. The Rubicon acquisition will allow the Takara Bio Group to augment and expand its worldwide commercial offerings in next generation sequencing (NGS) sample preparation and expand into new markets.
Read full release.